My take on the NEW website, Mannkind Technologies
Aug 3, 2014 16:01:41 GMT -5
BD and daduke38 like this
Post by nialla44 on Aug 3, 2014 16:01:41 GMT -5
This is my take:
Mannkind Technologies Corp. will be formed and split off from Mannkind Corp with Technosphere and the pipelines. Shares will be issued to Mannkind original shareholders for the Technologies Co., so now we will own a piece of two companies. If this scenario plays out, it will be very exciting, and the shorts are so screwed. Mannkind/Afrezza stand alone and partnered, and the other company with Technosphere and pipelines also partnering with other approved drugs, to improve delivery to the patient by advance inhalation using Technosphere. Absolutely HUGE markets.
The following is from the Annual Meeting Q & A
Question #3 from Attendee
"What are the other applications of the Technosphere platform, and what is Al's vision?"
In a very upbeat manner, Al Mann quickly stated, "The process offers a very very powerful way to deliver a drug very quickly into the blood and stabilize drugs that are not stable enough to deliver through many other technologies. A drug delivered for migraine headache now takes about an hour for a person to become comfortable. Imagine being able to deliver it (pain management medication) in 2 to 3 to 4 minutes and having freedom from a migraine. Wouldn't that be a big improvement? There are a lot of opportunities… But we have to concentrate first on getting Afrezza to market." President and COO Hakan Edstrom went on further to say, "We are looking at all organizations to get Afrezza to market on a global basis, and our vision is to create a MannKind Development Corp. as well, which would exploit the platform to other applications. There are a number of opportunities."
That could be the reason for the additional land & the new website under Mannkind Technologies.
Mannkind Technologies Corp. will be formed and split off from Mannkind Corp with Technosphere and the pipelines. Shares will be issued to Mannkind original shareholders for the Technologies Co., so now we will own a piece of two companies. If this scenario plays out, it will be very exciting, and the shorts are so screwed. Mannkind/Afrezza stand alone and partnered, and the other company with Technosphere and pipelines also partnering with other approved drugs, to improve delivery to the patient by advance inhalation using Technosphere. Absolutely HUGE markets.
The following is from the Annual Meeting Q & A
Question #3 from Attendee
"What are the other applications of the Technosphere platform, and what is Al's vision?"
In a very upbeat manner, Al Mann quickly stated, "The process offers a very very powerful way to deliver a drug very quickly into the blood and stabilize drugs that are not stable enough to deliver through many other technologies. A drug delivered for migraine headache now takes about an hour for a person to become comfortable. Imagine being able to deliver it (pain management medication) in 2 to 3 to 4 minutes and having freedom from a migraine. Wouldn't that be a big improvement? There are a lot of opportunities… But we have to concentrate first on getting Afrezza to market." President and COO Hakan Edstrom went on further to say, "We are looking at all organizations to get Afrezza to market on a global basis, and our vision is to create a MannKind Development Corp. as well, which would exploit the platform to other applications. There are a number of opportunities."
That could be the reason for the additional land & the new website under Mannkind Technologies.